← Back to catalogue

Rha® 3

FDA UDI

Class III (US FDA UDI)

by Teoxane SA

Identity

Trade Name
RHA® 3 FDA UDI
Generic Name
Dermal tissue reconstructive material, microbe-derived, anaesthetic FDA UDI
Device Name
One box of RHA® 3 contains two blisters and one instruction for use. Each blister contains a 1mL prefilled syringe and two needles (27G 1/2). Box Packaging (ID 07640173230038) is defined as unit of sales and identified with a serial number. FDA UDI
Model / Reference
RHA® 3 (1mL) FDA UDI
Description
One box of RHA® 3 contains two blisters and one instruction for use. Each blister contains a 1mL prefilled syringe and two needles (27G 1/2). Box Packaging (ID 07640173230038) is defined as unit of sales and identified with a serial number. FDA UDI

Identifiers

Catalog Number
940008 FDA UDI
Primary DI / UDI-DI
07640173230045 FDA UDI
FDA Product Code
LMH FDA UDI
GMDN Term
Dermal tissue reconstructive material, microbe-derived, anaesthetic FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
Not in Commercial Distribution FDA UDI

Clinical & Handling

Sterile

Yes

FDA UDI

Single Use

Yes

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

Yes

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Rha® 3 by Teoxane SA — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Teoxane SA

Sources (1)

  • FDA UDI f0117c68-3165-47bb-8801-192753f8171a 37 fields · synced May 30, 2026